ABBV STOCK HITS RECORD ALL TIME HIGH

Discussion in 'AbbVie' started by anonymous, Jun 14, 2017 at 12:17 PM.

Tags: Add Tags
  1. anonymous

    anonymous Guest

    This week Abbvie announces 3rd quarter numbers. Look for a big number and the stock will respond accordingly. It is funny how Abbvie is now the darling of Wall Street. The Amgen deal sealed another 5-6 years of growth. Wouldn't be surprised if the stock doubles in the next 2-3 years
     

  2. anonymous

    anonymous Guest

    This should be a big week for our company. Can't wait for Friday announcement. Can you say Abbvie $101
     
  3. anonymous

    anonymous Guest

    $96.10 USD -0.36 (0.37%)
    Closed: Oct 20, 7:06 PM EDT · Disclaimer
    After hours 96.20 +0.100 (0.10%)
     
  4. anonymous

    anonymous Guest

    Millennials lying their ass off here. Novel concept... try working.
     
  5. anonymous

    anonymous Guest

    Are you dillusional? JnJ announced their purchase of Nektar with an early phase 3 showing complete remission after 1 dose of a 75 ml injection. The drug HCt1326 is fast tracked. This is going to be over before it starts. If JnJ can muster a sales force (competent) we might be toast.
     
  6. anonymous

    anonymous Guest

    Abbvie stock is ready to move again. Look for a big move to $105-$109 range in January. After this the sky is the limit.
     
  7. anonymous

    anonymous Guest

    From a Stock Holder: THANK YOU
     
  8. anonymous

    anonymous Guest

    Wait until the lower corporate tax rate of 21% kicks in.You'll see Rick do what other CEOS will do. They won't create jobs or invest in R&D, they'll simply buy back thier own stock and FK the middle class. Little to no job growth from this. In 2004 Bush passed similar corporate tax cut. As Trump would say "It was a disaster" It grew into a massive giveaway that added to the complexity of the tax system and end up rewarding multinational companies that move jobs overseas. Love POTUS but he's greasing pockets of the greedy ones. Should have kept corporate tax where it was and gave that portion to lower and middle class folks. In a way, ( hate to admit) the looney dems are right. Follow the money trail ! ! !
     
  9. anonymous

    anonymous Guest

    YUGE tax corporate profits and low interest rates show clearly that it isn’t corporations profitability or insufficient available savings holding back investment. Corporations are sitting on plenty of cash but have used that money to boost shareholder returns, NOT investment ! ! This will be great for ABBV investors and shareholders by NOT middle class. Cutting corporate taxes solves no problem currently facing the American economy. Tax cuts for corporations are just tax cuts for the rich by another name. The gains from cutting corporate taxes will disproportionately accrue to the rich, since the top 1 percent holds 41% of stock wealth.
     
  10. anonymous

    anonymous Guest

    My broker says target of $225 share price by june.
     
  11. anonymous

    anonymous Guest

    My suggest, find another broker, he's smoking something illegal.
    Abbvie is certainly on the rise, but let's be realistic.
    Maybe another $25 - $35 in 2018... Maybe!!!
     
  12. anonymous

    anonymous Guest

    Agree! Let's hope there isn't anymore serious adverse events with Upadacitinib (ABT 494).Y'all had (2) patients who died in trials on a low dose. Technically, if and when when Abbv launches this, it wont only be competing with Enbrel and Xeljanz, it would also be up against your own Humira. WTF ?
     
  13. anonymous

    anonymous Guest

    boy r u a pessimist my broker sees a big pharma bubble with stocks up 300-400% in '18-19 then she says git out.
     
  14. anonymous

    anonymous Guest

    We will destroy Enbrel and Xeljanz.
     
  15. anonymous

    anonymous Guest

    Funny thing is in 60 months im up over 300% from IPO. Strong dividends make it even sweeter.The sweetest part is it cost me NOTHING , as a result of the Distribution of Abbott common shares at an aggregate tax basis.I never worked a day for Abbvie and reaped big bucks. How Sweet It Is !!! My Abbott stock did tank slightly after branded pharm was spun to AbbVie but I made substantial gains and now ABT is back headed north like ABBV.....EVERY Abbott shareholder got a piece of the pie and current and former C suite Abbott folks like me holds 10% of your stocks total value. BIG LEAGUE
     
  16. anonymous

    anonymous Guest

    ABBV is breaking $100 within minutes of opening bell today GUARANTEED !
     
  17. anonymous

    anonymous Guest

    My broker now says $250 share price is well within range by Q3 2018. I am bulking up on ABBV big time.
    Hope all those on CP also make a killing on this !
     
  18. anonymous

    anonymous Guest

    That would be wonderful, but you betttter find a new broker. Impossible feat. I'd settle for $115 by Q3 and be damn happy. Maybe I'll buy CP if they want to sell site. I'd offer couple mill cash deal and rid this site of the liars and posers.
     
  19. anonymous

    anonymous Guest

    100.00 USD +0.060 (0.060%)
    Jan 4, 9:30AM EST
     
  20. anonymous

    anonymous Guest

    $100.07 USD +.13 (0.06%)
    January 4th 9:30 AM EST

    $98.89 USD -1.05 (1.05%)
    January 4th 9:53 AM EST

    Couldn't hold a buck.